missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Procollagen I C-Peptide Polyclonal Antibody, Invitrogen™
Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA5145236
This item is not returnable.
View return policy
Description
Collagen type I is present in soft connective tissue and bone where it represents approximately 90% of the organix matrix. Collagen type I is produced from procollagen when two teloterminal propeptides are digested from the procursor and released into the circulation. The propeptide levels can be measured in serum as indicators of collagen production. Elevated values of these propeptides in serum are found in patients with various bone metabolism defects. Procollagen type I C-terminal propeptide (PICP) has a molecular weight of approximately 100 kDa and the normal range in serum depends on age and sex.
Specifications
| Procollagen I C-Peptide | |
| Polyclonal | |
| Unconjugated | |
| COL1A1 | |
| Alpha-1 type I collagen; alpha1(I) procollagen; COL1A1; collagen alpha 1 chain type I; collagen alpha-1(I) chain; collagen alpha-1(I) chain preproprotein; collagen of skin, tendon and bone, alpha-1 chain; collagen type I alpha 1; collagen, type I, alpha 1; C-terminal Collagen; EDSC; OI1; OI2; OI3; OI4; PICP; pro-alpha-1 collagen type 1; Procol; Procollagen; type I proalpha 1; type I procollagen alpha 1 chain | |
| Rabbit | |
| Antigen affinity chromatography, Protein A | |
| RUO | |
| 1277 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Immunohistochemistry (Paraffin), Western Blot, Western Blot | |
| 0.5 mg/mL | |
| PBS with 50% glycerol and 0.05% Proclin 300; pH 7.4 | |
| P02452 | |
| COL1A1 | |
| KLH conjugated Human CTXI protein, E1207-A1218 (Accession #Q9NPZ5). | |
| 20 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction